New class of drugs called SGLT2 glucose reabsorption inhibitors are pending FDA approval. These class of drugs reduce blood glucose levels in the body by way of excreting excess glucose through the kidneys.
New diabetes drugs may give hope to late stage diabetics
However, these new drugs could have undocumented side effects, therefore it is recommended to wait for sometime before taking them.